According to the newly submitted monthly return, Boill Healthcare Holdings Limited (01246) reported that its authorized share capital remained at 4,800,000,000 ordinary shares, each with a par value of HKD 0.25, maintaining a total authorized capital of HKD 1,200,000,000. The issued share capital also stood unchanged at 1,358,000,000 shares with no treasury shares.

The company verified compliance with the 25% minimum public float requirement for the reporting period. Regarding its share option scheme adopted on 27 September 2023, a maximum of 135,800,000 ordinary shares remains available for issuance, although no new shares were issued in January 2026. The monthly return further confirmed adherence to all relevant listing rules and regulatory conditions.